Title : Technical considerations in the development of circulating peptides as pharmacodynamic biomarkers for angiogenesis inhibitors.

Pub. Date : 2014 Jun

PMID : 24374901






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Repeated measures linear modeling from 15 patients demonstrated increased Ang2 (P <= 0.05) and decreased sVEGFR2 (P <= 0.05) after exposure to sorafenib. Sorafenib angiopoietin 2 Homo sapiens